Nasdaq
$227.70▼ 0.38%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $199.41BShares out 8.800M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
46- 1d agoAfter-hours26.10.24 05:058-KKey event#●●●#●●●
Marvell Technology, Inc.
On October 22, 2026, Marvell Technology, Inc. entered into a new $3 billion revolving credit agreement with a syndicate of lenders led by Bank of America, N.A. This agreement replaces the company's previous $1.5 billion facility and allows for an additional $2 billion increase in commitments under certain conditions. The proceeds will be used for general corporate purposes and working capital.…more
$227.70-0.38%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16After-hours26.10.17 06:184Ownership
Marvell Technology, Inc.
Marvell Technology insider Justin Scarpulla reported a change in beneficial ownership of securities as of October 15, 2026. This filing is a standard Form 4 disclosure regarding the insider's stock holdings.…more
$227.70-0.38%vs prev closeView filingShare - 10.16After-hours26.10.17 05:434Ownership
Marvell Technology, Inc.
Insider Chris Koopmans of Marvell Technology reported a change in beneficial ownership of securities via SEC Form 4 on October 15, 2026. This filing serves to transparently disclose changes in the executive's stock holdings to the market.…more
$227.70-0.38%vs prev closeView filingShare
45 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 6d agoPre-market26.10.19 19:45#●●●#●●●
Marvel Biosciences Selects CMAX as Phase I Clinical Trial Site for MB-204…more
Marvel Biosciences has selected CMAX in Australia as the clinical site for the Phase I trial of its lead drug candidate, MB-204. This selection marks an operational step toward first-in-human testing, pending necessary regulatory and ethics approvals.…more
$227.70-0.38%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.13Pre-market26.10.13 22:07
●●●●●●●● ●●●●● ●●●●●●
Marvell Technology, Microsoft, and Oracle have announced a collaboration under the Open Compute Project to standardize integrated HSMs for cloud and hyperscale data centers. This initiative aims to define open specifications to enhance security, reduce latency, and improve scalability for cloud workloads.…more
$227.70-0.38%vs prev closeShareBenzinga - 10.12Pre-market26.10.12 22:11
●●●●●●●● ●●●●● ●●●●●●
Marvell Technology has announced its second-generation Structera X CXL memory expanders to enhance efficiency and scalability for AI and cloud infrastructure. The new products are designed to meet the high-performance workload requirements of hyperscale data centers.…more
$227.70-0.38%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report